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LETTER Open Access
The COMET Initiative database: progress
and activities update (2015)
E. Gargon1*, P. R. Williamson1, D. G. Altman2, J. M. Blazeby3, S. Tunis4 and M. Clarke5
Abstract
This letter describes the substantial activity on the Core Outcome Measure in Effectiveness Trials (COMET) website
in 2015, updating our earlier progress reports for the period from the launch of the COMET website and database
in August 2011 to December 2014. As in previous years, 2015 saw further increases in the annual number of visits
to the website, the number of pages viewed and the number of searches undertaken. The sustained growth in use
of the website and database suggests that COMET is continuing to gain interest and prominence, and that the
resources are useful to people interested in the development of core outcome sets.
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Background
As the New Year bells were ringing and the fireworks
were exploding to welcome 2016 in cities such as Fray
Bentos in South America, an Internet user in Tianjin,
China ran the 10,000th search of the Core Outcome
Measures in Effectiveness Trials (COMET) database.
They were looking for information about non-small-cell
lung cancer (NSCLC), and will have been shown details
of two core outcome sets (COS) recently added to the
database [1, 2]. This letter describes the substantial ac-
tivity on the COMET website [3] in the 365 days before
that search. We update our earlier progress since the
launch of the COMET website and database in August
2011 to December 2014 [4, 5].
Activity and content
A total of 720 studies relevant to the development of
COS were included in the COMET database at the end
of December 2015, with 147 added during the year. This
included 32 reports relating to 29 COS identified in the
most recent update to the systematic review of COS [2],
which had originally been performed in 2013 [1].
As in previous years, 2015 saw further increases in the
annual number of visits to the website (Table 1) and
although the proportional change declined in 2015, the
absolute numbers continue to increase. For instance, the
proportional increase in new visitors from 2014 to 2015
was 33%, compared to 43% for 2013 to 2014; but the ab-
solute increase from 2014 to 2015 was 3269 compared
to 2936 for 2013 to 2014. Most visitors to the website ar-
rived either via links following an organic search using a
search engine, such as Google (68%), or direct (20%)
(Fig. 1). However, new for 2015, were arrivals from links
in emails, which is in large part attributable to the move
of the COMET newsletter from a PDF format to an
email format.
Social media also leads many people to the website
and Twitter accounted for 89% of social referrals to the
COMET website in 2015 (Table 2). The COMET Twitter
account is monitored by the research team and tweets
are sent when new COS papers are published, to announce
relevant presentations at conferences and to retweet
COS-related tweets from others that we follow. The
COMET account has more than 1300 followers and the
Twitter page links to the COMET website.
The highest proportions of referrals were from the
Core Outcomes in Women’s Health (CROWN) Initiative
(10%), the University of Liverpool (6%), Trials journal
(5%), MRC Hubs for Trials Methodology Research (5%),
Cochrane Canada (5%) and the Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT)
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initiative (4%). CROWN is an international initiative to
harmonise outcome reporting in women’s health re-
search. More than 70 journals have committed to en-
couraging the development and reporting of COS in
this area and CROWN advises all COS developers to
register with COMET [6]. Trials has published several
COS papers which generated referrals to the COMET
website, including ‘Developing core outcome sets for
clinical trials: issues to consider’ [7], the special collec-
tion of the meeting proceedings and abstracts from the
4th COMET meeting in Rome in November 2014, and
the report of the first meeting to discuss Trial Forge
[8]. The 5th COMET meeting was jointly hosted with
Cochrane Canada in Calgary in May 2015, hence the
large number of referrals from Cochrane Canada, and
the more than doubling in the annual number of visits
from Canada, from 624 in 2014 to 1449 in 2015
(Table 3). The referrals from SPIRIT reflect that initia-
tive’s encouragement of trial investigators to consider
measuring the outcomes in a COS in their trial as part
of their effort to improve the quality of clinical trial
protocols by defining an evidence-based set of items to
address in a protocol.
In 2015, there were a total 80,799 page views, a 10%
increase from 73,617 in 2014. Analyses of the COMET
website data show that 56% of visitors went beyond the
page on which they landed in 2015, similar to 2014 and,
as in previous years, the most common first interaction
was to search the COMET database. Other first interac-
tions included moving to the overview of the COMET
Initiative, accessing the database without completing a
search, and checking the resources page. This Core Re-
source Pack is once again the second most highly accessed
resource on the website (after the database), with 1372 page
views in 2015, compared to 1064 in 2014 (29% increase).
The total number of visits increased by 25% in 2015
compared to 2014.The number of unique visitors also
increased by 25%, and the number of new visitors increased
by 33%. Full details are provided in Table 1. Visitors came
from 127 countries, with 53% of visits now coming from
outside the UK, an increase of 2% from 8565/16,768 in
2014 to 11,090/20,952 in 2015 (Table 3).
Table 1 Core Outcome Measures in Effectiveness Trials (COMET) website usage statistics 2012 to 2015
Number of visits Number of unique visitors Number of new visitors Number of searches
Year 2012 2013 2014 2015 2012 2013 2014 2015 2012 2013 2014 2015 2012 2013 2014 2015
Total 7982 12332 16768 20952 5471 8369 12257 15366 4611 6844 9780 13049 1597 2139 2383 3411
Increase per year (%) n/a 55% 36% 25% n/a 53% 47% 25% n/a 48% 43% 33% n/a 34% 11% 43%
Overall increase from 2012
to 2015 (%)
163% 181% 183% 114%
Fig. 1 Core Outcome Measures in Effectiveness Trials (COMET) website acquisition overview
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By the end of December 2015 in the time zone of
the COMET website, a total of 9999 searches had
been undertaken in the COMET database, with 3411
in 2015 alone (a 43% increase from 2014). The most
frequently used search criteria were consistent with
previous years with the most frequently searched
category being Disease Category. The ‘top 10’ searched
for terms are shown in Table 4. In 2014, the most
commonly searched term was ‘cancer’ (n = 129) and
although this increased to 137 searches in 2015, it
was superseded in 2015 by ‘pregnancy and childbirth’
(n = 193).
Table 2 Examples of Twitter referrals
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In 2015, we conducted a pop-up survey to find out
why people were searching in the COMET database.
The survey appeared at the beginning of each search
during a 1-month period, asking people to select single
response to give their reason for searching in the
COMET database. Full details of the survey have been
published [2] but, in summary, it showed that the most
common reasons for searching the database were to in-
form decision-making about developing a COS, or to in-
form the outcomes in planning a clinical trial. The pop-
up survey also confirmed the importance of keeping the
contents of the database up to date, if it is to help re-
searchers to avoid unnecessary duplication of effort and
minimise waste [9].
The sustained growth in use of the website and data-
base suggests that COMET is continuing to gain interest
and prominence, and that the resources are useful to
people interested in COS development. To help ensure
that the content is kept up to date a second update of
the systematic review of COS [1, 2] is underway and the
COMET website and database usage figures will con-
tinue to be monitored and assessed annually.
Abbreviations
COMET: Core Outcome Measures in Effectiveness Trials; COS: Core outcome
set(s); CROWN: Core Outcomes in Women’s Health; NSCLC: Non-small-cell
lung cancer; SPIRIT: Standard Protocol Items: Recommendations for
Interventional Trials
Acknowledgements
Ms. Mel Major, Associate Professor Marike vander Schaaf and Professor Dale
Needham consent for their Twitter profiles and tweets to be used in this
manuscript.
Funding
This work was supported by the MRC North West Hub for Trials
Methodology Research (MR/K025635/1), and the NIHR Senior Investigators
Award (NF-SI_0513-10025).
Availability of data and materials
Not applicable (but data used to prepare the tables is available from the
authors).
Authors’ contributions
EG and MC conceived the idea for these periodic reports. EG performed the
analysis. EG, PW, MC, JB, ST and DA interpreted data. EG wrote the
manuscript. All authors read and approved the final manuscript.
Competing interests
DA, JB, MC, ST and PW are members of the COMET Management Group and
coapplicants on grants to support COMET and related work. EG is a member
of the COMET Management Group and is the COMET project coordinator.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Author details
1Department of Biostatistics, University of Liverpool, 1st floor Duncan
Building, Daulby Street, Liverpool L69 3GA, UK. 2University of Oxford, Centre
for Statistics in Medicine, Botnar Research Centre, Windmill Road, Oxford OX3
7LD, UK. 3School of Social and Community Medicine, University of Bristol,
Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK. 4Center for Medical
Technology Policy (CMTP), World Trade Center Baltimore, 401 East Pratt
Street, Suite 631, Baltimore, MD 21202, USA. 5Queen’s University Belfast,
Institute of Clinical Sciences, Block B, Royal Hospitals, Grosvenor Road, Belfast
BT12 6BJ, UK.
Received: 25 May 2016 Accepted: 9 January 2017
Table 3 Countries with the most visits to the Core Outcome Measure in Effectiveness Trials (COMET) website in 2012 to 2015
2012 2013 2014 2015
United Kingdom 5577 United Kingdom 7526 United Kingdom 8203 United Kingdom 9862
United States 431 United States 1022 United States 2038 United States 2444
Canada 326 Canada 501 Italy 1115 Canada 1449
Australia 201 Australia 321 Canada 624 Australia 654
Germany 186 Italy 315 Germany 581 France 593
Netherlands 166 Netherlands 308 Netherlands 510 Netherlands 570
Italy 161 Germany 285 Australia 494 Germany 553
France 125 Japan 228 France 374 India 477
Ireland 113 France 227 India 306 Italy 439
Norway 62 Ireland 159 Ireland 239 Ireland 415
Table 4 ‘Top 10’ search terms in 2015
Category Number
Pregnancy and childbirth 193
Cancer 137
Neurology 88
Mental health 79
Gynaecology 77
Skin 76
Heart and circulation 69
Anaesthesia and pain control 68
Dentistry and oral health 65
Orthopaedics and trauma 65
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